Cargando…

HOXA11 gene is hypermethylation and aberrant expression in gastric cancer

BACKGROUND: Aberrant DNA methylation is an acquired epigenetic alteration that serves as an alternative to genetic defects in the inactivation of tumor suppressor genes and other genes in diverse human cancers. Gastric carcinoma is one of the tumors with a high frequency of aberrant methylation in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Yinguo, Fang, Na, Gu, Tingxun, Kang, Yuhua, Wu, Jiang, Yang, Desheng, Zhang, Hui, Suo, Zhimin, Ji, Shaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364045/
https://www.ncbi.nlm.nih.gov/pubmed/25788862
http://dx.doi.org/10.1186/s12935-014-0079-7
_version_ 1782362012591849472
author Bai, Yinguo
Fang, Na
Gu, Tingxun
Kang, Yuhua
Wu, Jiang
Yang, Desheng
Zhang, Hui
Suo, Zhimin
Ji, Shaoping
author_facet Bai, Yinguo
Fang, Na
Gu, Tingxun
Kang, Yuhua
Wu, Jiang
Yang, Desheng
Zhang, Hui
Suo, Zhimin
Ji, Shaoping
author_sort Bai, Yinguo
collection PubMed
description BACKGROUND: Aberrant DNA methylation is an acquired epigenetic alteration that serves as an alternative to genetic defects in the inactivation of tumor suppressor genes and other genes in diverse human cancers. Gastric carcinoma is one of the tumors with a high frequency of aberrant methylation in promoter region. Hence we investigated the promoter methylation status and expression level of HOXA11 gene which may involve in GC development. METHODS: Thirty-two surgical excised gastric cancer specimens, twelve paired adjacent non-cancerous specimens and seven normal gastric mucosas were examined. The methylation status and expression level of HOXA11 gene were determined by bisulfite sequencing polymerase chain reaction (BSP), real-time polymerase chain reaction (RT-PCR) and immunohistochemistry (IHC) respectively. HOXA11 expression was knocked-down with siRNA to mimic HOXA11 gene hypermethylation and ability of cell proliferation and migration was determinate. In addition, we analyzed and correlated the findings with clinicopathological features. RESULTS: The methylation level of HOXA11 gene in gastric cancer tissues and adjacent non-cancerous tissues were higher than those in normal gastric mucosa (P < 0.05). The methylation level was higher in TNM III and IV patients of GC than those in TNM I and II patients (P < 0.05). The expression of HOXA11 mRNA and protein decreased in normal gastric mucosa, peri-cancer tissue and GC (P < 0.05). HOXA11 expression was inversely correlated with DNA methylation (P < 0.05). Knocked-down of HOXA11 expression with siRNA in BGC-823 cells enhanced cell proliferation compared with control, but no significant different was observed in migration ability. CONCLUSION: Hypermethylation and decreased expression of HOXA11 gene may be involved in the carcinogenesis and development of GC and may provide useful information for the prediction of the malignant behaviors of GC. And the expression of HOXA11 is impaired by DNA methylation. However, repression of HOXA11 expression promoted BGC-823 cell proliferation.
format Online
Article
Text
id pubmed-4364045
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43640452015-03-19 HOXA11 gene is hypermethylation and aberrant expression in gastric cancer Bai, Yinguo Fang, Na Gu, Tingxun Kang, Yuhua Wu, Jiang Yang, Desheng Zhang, Hui Suo, Zhimin Ji, Shaoping Cancer Cell Int Primary Research BACKGROUND: Aberrant DNA methylation is an acquired epigenetic alteration that serves as an alternative to genetic defects in the inactivation of tumor suppressor genes and other genes in diverse human cancers. Gastric carcinoma is one of the tumors with a high frequency of aberrant methylation in promoter region. Hence we investigated the promoter methylation status and expression level of HOXA11 gene which may involve in GC development. METHODS: Thirty-two surgical excised gastric cancer specimens, twelve paired adjacent non-cancerous specimens and seven normal gastric mucosas were examined. The methylation status and expression level of HOXA11 gene were determined by bisulfite sequencing polymerase chain reaction (BSP), real-time polymerase chain reaction (RT-PCR) and immunohistochemistry (IHC) respectively. HOXA11 expression was knocked-down with siRNA to mimic HOXA11 gene hypermethylation and ability of cell proliferation and migration was determinate. In addition, we analyzed and correlated the findings with clinicopathological features. RESULTS: The methylation level of HOXA11 gene in gastric cancer tissues and adjacent non-cancerous tissues were higher than those in normal gastric mucosa (P < 0.05). The methylation level was higher in TNM III and IV patients of GC than those in TNM I and II patients (P < 0.05). The expression of HOXA11 mRNA and protein decreased in normal gastric mucosa, peri-cancer tissue and GC (P < 0.05). HOXA11 expression was inversely correlated with DNA methylation (P < 0.05). Knocked-down of HOXA11 expression with siRNA in BGC-823 cells enhanced cell proliferation compared with control, but no significant different was observed in migration ability. CONCLUSION: Hypermethylation and decreased expression of HOXA11 gene may be involved in the carcinogenesis and development of GC and may provide useful information for the prediction of the malignant behaviors of GC. And the expression of HOXA11 is impaired by DNA methylation. However, repression of HOXA11 expression promoted BGC-823 cell proliferation. BioMed Central 2014-08-19 /pmc/articles/PMC4364045/ /pubmed/25788862 http://dx.doi.org/10.1186/s12935-014-0079-7 Text en Copyright © 2014 Bai et al.; licensee Springer http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Primary Research
Bai, Yinguo
Fang, Na
Gu, Tingxun
Kang, Yuhua
Wu, Jiang
Yang, Desheng
Zhang, Hui
Suo, Zhimin
Ji, Shaoping
HOXA11 gene is hypermethylation and aberrant expression in gastric cancer
title HOXA11 gene is hypermethylation and aberrant expression in gastric cancer
title_full HOXA11 gene is hypermethylation and aberrant expression in gastric cancer
title_fullStr HOXA11 gene is hypermethylation and aberrant expression in gastric cancer
title_full_unstemmed HOXA11 gene is hypermethylation and aberrant expression in gastric cancer
title_short HOXA11 gene is hypermethylation and aberrant expression in gastric cancer
title_sort hoxa11 gene is hypermethylation and aberrant expression in gastric cancer
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364045/
https://www.ncbi.nlm.nih.gov/pubmed/25788862
http://dx.doi.org/10.1186/s12935-014-0079-7
work_keys_str_mv AT baiyinguo hoxa11geneishypermethylationandaberrantexpressioningastriccancer
AT fangna hoxa11geneishypermethylationandaberrantexpressioningastriccancer
AT gutingxun hoxa11geneishypermethylationandaberrantexpressioningastriccancer
AT kangyuhua hoxa11geneishypermethylationandaberrantexpressioningastriccancer
AT wujiang hoxa11geneishypermethylationandaberrantexpressioningastriccancer
AT yangdesheng hoxa11geneishypermethylationandaberrantexpressioningastriccancer
AT zhanghui hoxa11geneishypermethylationandaberrantexpressioningastriccancer
AT suozhimin hoxa11geneishypermethylationandaberrantexpressioningastriccancer
AT jishaoping hoxa11geneishypermethylationandaberrantexpressioningastriccancer